Matches in Nanopublications for { ?s ?p "[The frequency of miR-126 downregulation was 100.0% in FAP adenomas, 85.7% in FAP intramucosal carcinomas, 78.9% in invasive carcinomas, 81.3% in Lynch syndrome tumors, 68.4% in MSS tumors, and 65.4% in MSI-H tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP1198495.RAiSoIaC1sqFppqjGsxVooo_IfEUUQnpXWkm0AStcjWZo130_assertion description "[The frequency of miR-126 downregulation was 100.0% in FAP adenomas, 85.7% in FAP intramucosal carcinomas, 78.9% in invasive carcinomas, 81.3% in Lynch syndrome tumors, 68.4% in MSS tumors, and 65.4% in MSI-H tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1198495.RAiSoIaC1sqFppqjGsxVooo_IfEUUQnpXWkm0AStcjWZo130_provenance.
- NP993143.RA7krWHnk6Kn13tMACfrZsnlSRCIRQYTHfsPytjEJYwxU130_assertion description "[The frequency of miR-126 downregulation was 100.0% in FAP adenomas, 85.7% in FAP intramucosal carcinomas, 78.9% in invasive carcinomas, 81.3% in Lynch syndrome tumors, 68.4% in MSS tumors, and 65.4% in MSI-H tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP993143.RA7krWHnk6Kn13tMACfrZsnlSRCIRQYTHfsPytjEJYwxU130_provenance.